NCT01217112 - GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II Diabetes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

May 31, 2012

Study Completion Date

September 30, 2012

Conditions

DyslipidemiasDiabetes Mellitus, Type 2

Interventions

DRUG

GWP42003

100 mg capsules, PO, BD, 91 days

DRUG

GWP42003

5 mg capsules, PO, BD, 91 days

DRUG

GWP42004

5 mg capsules, PO, BD, 91 days

DRUG

Placebo

0 mg capsules, QDS, PO, 91 days

Trial Locations (5)

Woolpit Health Centre, Bury Saint Edmonds

Mount Farm Surgery, Bury Saint Edmonds

University of Nottingham, Medical School at Derby, Royal Derby Hospital, Derby

James Paget University Hospital, Gorleston-on-Sea, Norfolk

MAC UK Neuroscience Ltd., Manchester